ETIDRONATE 400 MG — DIN 02347970
ETIDRONATE DISODIUM : 400 MG · COBALT PHARMACEUTICALS COMPANY · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED PRE MARKET
What is ETIDRONATE?
ETIDRONATE 400 MG contains ETIDRONATE DISODIUM : 400 MG. It is listed in the Health Canada Drug Product Database under DIN 02347970, held by COBALT PHARMACEUTICALS COMPANY, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 01-Sep-2017. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is ETIDRONATE used for?
ETIDRONATE (etidronate disodium) is indicated for: treatment of symptomatic Paget's disease of the bone (osteitis deformans); for the short-term (30-90 days) maintenance of clinically acceptable serum calcium levels following treatment with etidronate disodium I.V. Infusion (for patients with hypercalcemia of malignancy).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Etidronic Acid in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
6 holders have a Canadian DIN containing Etidronic Acid, across 9 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| APOTEX INC | 2 | 0 | APO-ETIDRONATE | No marketed DIN |
| COBALT PHARMACEUTICALS COMPANY | 2 | 0 | ETIDRONATE | No marketed DIN |
| TEVA CANADA LIMITED | 2 | 0 | ACT ETIDRONATE | No marketed DIN |
| MGI PHARMA INC. | 1 | 0 | DIDRONEL INJ 50MG/ML | No marketed DIN |
| MYLAN PHARMACEUTICALS ULC | 1 | 0 | MYLAN-ETIDRONATE | No marketed DIN |
| PROCTER & GAMBLE PHARMACEUTICALS CANADA INC | 1 | 0 | DIDRONEL TAB 200MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 400 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | Blisters of 14 tablets and bottles of 100 and 500 tablets. |
| Storage | Store at room temperature (15-30°C). |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Etidronic Acid |
|---|---|
| ATC code | M05BA01 |
| AHFS class | 92:24.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02347970 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2347970 |
| Brand name | ETIDRONATE |
| Generic / active ingredient | ETIDRONATE DISODIUM : 400 MG |
| Market authorization holder | COBALT PHARMACEUTICALS COMPANY |
| Health Canada schedule | Prescription |
| ATC code | M05BA01 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M05BA |
| Current status | CANCELLED PRE MARKET |
| Status date | 01-Sep-2017 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 9 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACT ETIDRONATE | 400 MG | TABLET | TEVA CANADA LIMITED | CANCELLED PRE MARKET | 02248687 |
| ACT ETIDRONATE | 200 MG | TABLET | TEVA CANADA LIMITED | CANCELLED POST MARKET | 02248686 |
| APO-ETIDRONATE | 400 MG | TABLET | APOTEX INC | CANCELLED PRE MARKET | 02276852 |
| APO-ETIDRONATE | 200 MG | TABLET | APOTEX INC | CANCELLED PRE MARKET | 02276844 |
| DIDRONEL INJ 50MG/ML | 50 MG | SOLUTION | MGI PHARMA INC. | CANCELLED POST MARKET | 01908480 |
| DIDRONEL TAB 200MG | 200 MG | TABLET | PROCTER & GAMBLE PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | 01997629 |
| ETIDRONATE | 200 MG | TABLET | COBALT PHARMACEUTICALS COMPANY | CANCELLED PRE MARKET | 02347962 |
| MYLAN-ETIDRONATE | 200 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | 02245330 |
2 · Same class — other molecules in ATC M05BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Risedronic Acid | AA-RISEDRONATE DR · ACTONEL · ACTONEL DR · APO-RISEDRONATE · +15 more | 40 | 20 | Yes |
| Alendronic Acid | ACCEL-ALENDRONATE · ACH-ALENDRONATE · ACT ALENDRONATE · AG-ALENDRONATE · +31 more | 79 | 17 | Yes |
| Zoledronic Acid | ACLASTA · ACT ZOLEDRONIC ACID · ACT ZOLEDRONIC ACID CONCENTRATE · JAMP-ZOLEDRONIC ACID · +14 more | 26 | 9 | Yes |
| Pamidronic Acid | AREDIA · AREDIA 30MG · AREDIA 90MG · AREDIA LIQ INJ 3MG/ML · +6 more | 23 | 8 | Yes |
| Clodronic Acid | BONEFOS · CLASTEON · OSTAC CAP 400MG | 4 | 1 | Yes |
| Etidronic Acid | ACT ETIDRONATE · APO-ETIDRONATE · DIDRONEL INJ 50MG/ML · DIDRONEL TAB 200MG · +2 more | 9 | 0 | Not in Canada |
| Ibandronic Acid | BONDRONAT | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M05B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M05BX | Burosumab · Denosumab · Romosozumab | 9 | 8 |
| M05BB | Alendronic Acid And Cholecalciferol · Etidronic Acid And Calcium, Sequential · Risedronic Acid And Calcium, Sequential · Risedronic Acid, Calcium And Cholecalciferol, Sequential | 22 | 6 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.